Instituto Nacional de Medicina Genómica

Profile narrative

The Instituto Nacional de Medicina Genómica (INMEGEN) is a Mexican public institution dedicated to advancing genomic medicine through research, clinical services, and education. Its core activities include conducting scientific studies on the genetic basis of diseases, offering diagnostic genetic testing and counseling, and developing public health strategies that integrate genomic information into preventive care. INMEGEN also provides training programs for health professionals and collaborates with academic and healthcare institutions to translate genomic discoveries into improved patient outcomes.

As a national institute under Mexico’s Secretariat of Health, INMEGEN serves the entire Mexican population, addressing health needs across diverse geographic and socioeconomic groups. Its mandate encompasses both rare and common diseases, with a particular focus on conditions that have a significant genetic component within the Mexican populace. The institute’s work contributes to national health surveillance and informs policy decisions related to genomic health initiatives.

INMEGEN distinguishes itself through its specialization in genomic medicine, positioning it as a leading authority in the country for integrating genetics into clinical practice and public health. Notably, the institute was involved in COVID‑19 research, which highlighted its capacity to respond to emerging health threats using genomic approaches. Its notable competencies include pharmacogenomics, population genetics, and the development of genomic databases that support personalized medicine initiatives.

Structurally, INMEGEN operates as a government agency, reporting directly to the Secretariat of Health and receiving federal funding to fulfill its national mandate. It does not have private shareholders or subsidiaries, functioning instead as a centralized entity that coordinates genomic efforts across Mexico’s health system. This governmental affiliation ensures alignment with national health priorities and facilitates collaboration with other public health organizations.

Incidents

1 incident linked to this organisation.